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Anaplasma phagocytophilum transmembrane and surface proteins play a role during
infection and multiplication in host neutrophils and tick vector cells. Recently, A.
phagocytophilum Major surface protein 4 (MSP4) and Heat shock protein 70 (HSP70)
were shown to be localized on the bacterial membrane, with a possible role during
pathogen infection in ticks. In this study, we hypothesized that A. phagocytophilumMSP4
and HSP70 have similar functions in tick-pathogen and host-pathogen interactions. To
address this hypothesis, herein we characterized the role of these bacterial proteins
in interaction and infection of vertebrate host cells. The results showed that A.
phagocytophilum MSP4 and HSP70 are involved in host-pathogen interactions, with
a role for HSP70 during pathogen infection. The analysis of the potential protective
capacity of MSP4 and MSP4-HSP70 antigens in immunized sheep showed that MSP4-
HSP70 was only partially protective against pathogen infection. This limited protection
may be associated with several factors, including the recognition of non-protective
epitopes by IgG in immunized lambs. Nevertheless, these antigens may be combined
with other candidate protective antigens for the development of vaccines for the control of
human and animal granulocytic anaplasmosis. Focusing on the characterization of host
protective immune mechanisms and protein-protein interactions at the host-pathogen
interface may lead to the discovery and design of new effective protective antigens.
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INTRODUCTION
Anaplasma phagocytophilum (Rickettsiales: Anaplasmataceae) is an emerging tick-borne
intracellular bacterial pathogen in many regions of the world, but vaccines are not available for
prevention of transmission and infection in humans and animals (Dumler et al., 2001; Severo et al.,
2013; Stuen et al., 2013, 2015; Bakken and Dumler, 2015). Anaplasma phagocytophilum causes
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human granulocytic anaplasmosis (HGA), which has emerged
as a tick-borne disease of humans in the United States, Europe
and Asia (Severo et al., 2013). In Europe, A. phagocytophilum
is an established pathogen of small ruminants, most notably
in sheep, where it was first described as the etiologic agent
of tick-borne fever (TBF; Gordon et al., 1932; Foggie, 1951;
Dugat et al., 2015). Clinical presentation of A. phagocytophilum
infection has been also documented in goats, cattle, horses, dogs,
cats, roe deer, and reindeer (Severo et al., 2013). Although, A.
phagocytophilum is recognized as a threat for human and animal
health in Europe and the United States, its pathogenic and
epidemic potential is neglected in tropical regions of the world
(Heyman et al., 2010; Dugat et al., 2015). Prophylactic uses of
tetracycline together with acaricide applications for tick control
are the main measures to controlA. phagocytophilum infection in
endemic areas (Woldehiwet, 2006; Stuen et al., 2015). However,
these control measures raise concerns about their impact on the
environment and human health, and the selection of resistant
pathogens and ticks (Woldehiwet, 2006; Stuen et al., 2015).
Results using next generation sequencing technologies have
advanced our understanding of the mechanisms by which
A. phagocytophilum infection affects gene expression, protein
content and microbiota in the vertebrate host and tick vector
(Ge and Rikihisa, 2006; Sukumaran et al., 2006; de la Fuente
et al., 2010, 2016a,b,c,d, 2017, Neelakanta et al., 2010; Rikihisa,
2011; Severo et al., 2012; Ayllón et al., 2013, 2015; Hajdušek
et al., 2013; Villar et al., 2015a; Cabezas-Cruz et al., 2016, 2017;
Gulia-Nuss et al., 2016; Abraham et al., 2017; Mansfield et al.,
2017). However, less information is available on the bacterial
molecules involved in pathogen infection and multiplication
(Ge and Rikihisa, 2007; Huang et al., 2010; Lin et al., 2011;
Troese et al., 2011; Mastronunzio et al., 2012; Oliva Chávez
et al., 2015; Seidman et al., 2015; Villar et al., 2015b; Truchan
et al., 2016). Definition of bacterial proteins involved in host-
pathogen and vector-pathogen interactions may provide target
antigens for the development of vaccines and therapeutics that
interfere with pathogen host infection and transmission by ticks
(Gomes-Solecki, 2014; de la Fuente and Contreras, 2015).
Recently, Villar et al. (2015b) demonstrated that A.
phagocytophilum activates a new mechanism associated
with bacterial cell stress and membrane proteins to counteract
tick cell response to infection and favor pathogen infection and
multiplication. Their results showed that A. phagocytophilum
proteins, Major surface protein 4 (MSP4) and Heat shock protein
70 (HSP70), are localized on the bacterial membrane where
they interact with a possible role during pathogen infection
in ticks (Villar et al., 2015b). Furthermore, antibodies against
MSP4 and HSP70 inhibited pathogen infection of tick cells,
supporting that these proteins are involved in tick-pathogen
interactions (Villar et al., 2015b). They proposed that the
inhibitory effect of anti-MSP4 and anti-HSP70 antibodies could
be the result of the antibodies blocking the interaction between
bacterial ligands (e.g., MSP4) and tick receptors or an effect on
proteins functionally important for bacterial infection and/or
multiplication in tick cells (e.g., HSP70 and those physically
and/or functionally interacting with it; Villar et al., 2015b). The
results of these experiments suggested that A. phagocytophilum
MSP4 and HSP70 proteins constitute candidate protective
antigens to interfere with pathogen infection in the tick vector,
Ixodes scapularis.
The characterization of the A. phagocytophilum proteome
demonstrated that chaperones, surface and stress response
proteins are among the most abundant proteins found in I.
scapularis tick salivary glands (Mastronunzio et al., 2012). HSP70
is a chaperone involved in protein folding and stress response
(Johnson, 2012). This protein functions by protecting cells from
stress-induced lethal damage and under physiological growth
conditions by acting as carriers for immunogenic peptides,
assisting in protein export or mediating adherence to host cells
and may play an essential role during cell division (Scopio et al.,
1994; Susin et al., 2006; Multhoff, 2007; Seydlová et al., 2012). The
role of MSPs such as MSP4 in adhesion to tick cells for bacterial
infection has been demonstrated in A. marginale (de la Fuente
et al., 2001) and A. phagocytophilum (Villar et al., 2015b).
Anaplasma phagocytophilum infects vertebrate host
neutrophils and various tick tissues, where it develops within
membrane-bound inclusions in the cell cytoplasm (Severo et al.,
2013). However, this pathogen has evolved common molecular
mechanisms to establish infection in tick vectors and vertebrate
hosts that collectively mediate pathogen infection, development,
persistence, and survival (de la Fuente et al., 2016a). These
strategies include, but are not limited to, remodeling of the
cytoskeleton, inhibition of cell apoptosis, manipulation of
the immune response, and the use of rickettsial proteins for
infection and manipulation of tick and host gene expression
(Cabezas-Cruz et al., 2016; de la Fuente et al., 2016a).
Based on these results, we hypothesized that the use of
common strategies by A. phagocytophilum to establish infection
in ticks and vertebrate hosts resulted in similar functions for
MSP4 and HSP70 proteins in host-pathogen and tick-pathogen
interactions. To address this hypothesis, in this study we
characterized the role of these bacterial proteins in infection of
vertebrate host cells and their potential protective capacity in
immunized sheep. The results showed that A. phagocytophilum
MSP4 and HSP70 are involved in host-pathogen interactions
during pathogen infection, but were only partially protective
against pathogen infection in sheep.
MATERIALS AND METHODS
Ethics Statement
The study was ethically approved by the local Animal Health and
Welfare Authority (Diputación Foral de Alava) with reference
No. 1820, 12th May 2015, following Spanish ethical guidelines
and animal welfare regulations (Real Decreto 53/2013).
Production of Recombinant Proteins and
Rabbit Antibodies
The His-tag recombinant A. phagocytophilum human NY18
isolate (Asanovich et al., 1997) proteins MSP4 (AFD54597) and
HSP70 (KX891324) were produced in Escherichia coli BL21 cells
(Champion pET101 Directional TOPO Expression kit, Carlsbad,
CA, USA), after induction with IPTG and purified using the
Ni-NTA affinity column chromatography system (Qiagen Inc.,
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Valencia, CA, USA) as previously described (Villar et al., 2015b).
Recombinant purified proteins showed purity higher than 85% of
total proteins and were used to immunize rabbits to purify IgGs
from preimmune and immunized animals (Montage Antibody
Purification Kit and Spin Columns with PROSEP-A Media,
Millipore, Billerica, MA, USA) for Western blot and antibody
inhibition analyses as previously described (Villar et al., 2015b).
Surface Trypsin Digestion of
A. phagocytophilum from Infected HL60
Human Cells
The A. phagocytophilum human NY18 isolate was propagated
in cultured HL60 human promyelocytic cells as previously
described (de la Fuente et al., 2005). The A phagocytophilum-
infected cells (∼1 × 107 cells) were collected when 70–80% of
the cells were infected as determined by detection of intracellular
morulae in stained cytospin cell smears. Host cell-free bacteria
were isolated from cell lysates after five passages through a 27-
gauge syringe, followed by differential centrifugation in Percoll
gradients as previously described for A. marginale to separate
bacteria from host cell debris (Lis et al., 2014). The pellet of
purified A. phagocytophilum was resuspended in 200µl of SPG
buffer (0.25mM sucrose, 10mM sodium phosphate, 5mM L-
glutamic acid, pH 7.2), and 5µl of sequencing-grade trypsin
(Promega, Madison, WI, USA) was added to half of the cell
reaction mixture. Bacteria were incubated at 37◦C for 30min
and then centrifuged at 10,000 × g for 15min and resuspended
in Laemmli protein loading buffer, boiled for 5min and loaded
onto a 12% SDS-PAGE and analyzed byWestern blot using rabbit
antibodies against recombinant MSP4 and HSP70 proteins as
previously described (Villar et al., 2015b).
Tertiary Models and Protein-Protein
Docking
The active A. phagocytophilum HSP70 and MSP4 proteins were
modeled using I-TASSER (Zhang, 2008), and the unbound (apo)-
HSP70 protein was modeled using Robetta (Kim et al., 2004). All
tertiary models were optimized with the Schrödinger’s Maestro
Protein Preparation Wizard (Li et al., 2007). All steric clashes
were resolved via minimization with the default settings in
the Schrodinger’s Maestro package. For the tertiary models,
the Protein Preparation Wizard clusters at the highest degree
of hydrogen bonding in equilibrium were used. Monte Carlo
orientations were performed (100,000) for each cluster. The
optimized structure is based on electrostatic and geometric
scoring functions. The membrane positioning for MSP4 was
calculated by the OPM database (Lomize et al., 2006) and
generated using the Desmond systems builder (Bowers et al.,
2006) as part of the Schrodinger’s Maestro package. The
protein-protein docking was assessed using the SwarmDock
server (Torchala et al., 2013) that incorporates flexible docking
by exploring in proximity to the Cartesian center of mass
of the target protein. Minimization steps are included for
the whole system. The poses are calculated based on the
most energy favorable poses, minimized once again and sent
to the user. We chose to analyze the top 10 poses since
these were highly energy favorable (−41 to −54 kcal/mol).
The server also produces the residue contacts made between
both proteins. All structures were visualized and analyzed
using the Visual Molecular Dynamics (Humphrey et al.,
1996).
Adhesion of Recombinant E. coli Strains to
HL60 Human Cells
The adhesion of recombinant E. coli strains to HL60 human
cells was characterized as previously reported (de la Fuente
et al., 2001; Villar et al., 2015b). Briefly, E. coli strains
producingA. phagocytophilumMSP4, HSP70, andmutantHSP70
with truncated peptide-binding domains that are involved in
protein-protein interactions (Villar et al., 2015b) recombinant
proteins were grown and induced as described before. The
E. coli cells transformed with expression vector alone were
used as negative control. Cell densities were determined and
adjusted to 108 cells per ml in Luria Broth (LB). One hundred
microliters (107 bacteria) culture were added to 900µl of 106
cells per ml suspensions of HL60 human cells in LB. Human
cells and bacteria were incubated for 30min at 37◦C with
occasional agitation. Cells were then collected by centrifugation,
washed two times in PBS and resuspended in 100ml of
PBS. Elimination of unbound bacteria from human cells with
bound bacteria was performed by Percoll (Sigma, St. Louis,
MI, USA) gradient separation (de la Fuente et al., 2001). The
band containing human cells was removed with a pipette and
washed in PBS. The final cell pellet was lysed in 1ml of
sterile water and 5µl plated onto LB agar plates containing
100µg of ampicillin per ml. Two replicates were done for
each experiment. Adhesive bacteria were quantitated as the
number of colony forming units (CFU) recovered from each test
and compared to the control values by Chi2 test (P = 0.001;
N = 2).
Transmission Electron Microscopy (TEM)
The HL60 human cells incubated as described above with E.
coli strains producing A. phagocytophilum MSP4 and HSP70
recombinant proteins or transformed with expression vector
alone as controls were pelleted and fixed in 2.5% glutaraldehyde
in 0.1M phosphate buffer for 1 h at room temperature. Fixed
cells were washed three times in 0.1M phosphate buffer with
4% glucose and embedded in 2% agar at 60◦C. Samples
were post-fixed using 2% OsO4 for 2 h at room temperature,
three times washed and dehydrated in a graded series of
acetone (30–100%) solutions for 15min at each step. Samples
were infiltrated with 25, 50, and 75% solutions of Spi Pon
Epoxy resin (Structure Probe, Inc. Supplies, West Chester,
PA, USA) diluted in anhydrous acetone for 1 h at each step.
Samples were left in 100% resin overnight, transferred to
embedding molds and polymerized at 60◦C for 48 h. Ultrathin
sections were contrasted in ethanolic uranyl acetate and lead
citrate, carbon coated and observed in a JEOL 1010 TEM
(JEOL Ltd., Akishima, Tokio, Japan) at an accelerating voltage
of 80 kV. Images were captured using a Mega View III
camera (Olympus Soft Imaging Solutions GmbH, Münster,
Germany).
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Prediction of B-cell Epitopes
Anaplasma phagocytophilum MSP4 (AFD54597) and HSP70
(AAC31306) amino acid sequences were aligned using MAFFT
version 7, applying a gap opening penalty of 3 (range 1–3,
default 1.53; Katoh and Standley, 2013). Sequence homology
was calculated using Clustal Omega (Sievers et al., 2011).
The linear B-cell epitopes on A. phagocytophilum MSP4
and HSP70 proteins were predicted using the Bepipred
Linear Epitope Prediction tool (http://tools.immuneepitope.
org/bcell/; Haste Andersen et al., 2006; Larsen et al., 2006;
Ponomarenko and Bourne, 2007). Subsequently, to search
for epitope homology, each predicted epitope within each
protein was aligned with the full sequence of the other
protein.
Antibody Inhibition Assay
The inhibitory effect of rabbit IgG antibodies against MSP4
and HSP70 recombinant proteins on A. phagocytophilum human
NY18 (Asanovich et al., 1997) and sheep (Alberdi et al.,
2015) isolates infection of HL60 human cells was conducted
as described previously for tick cells (Villar et al., 2015b). The
inhibitory effect of IgG antibodies purified from MSP4 and
MSP4-HSP70 immunized and control sheep at 0 and 94 days
post-infection (dpi) on A. phagocytophilum human NY18 isolate
infection of HL60 human cells was conducted using the same
experimental approach as for rabbit IgG. The IgGs were purified
from sheep sera using the NAb Protein G spin kit (Thermo
Fisher Scientific, Waltham, MA, USA) following manufacturer’s
recommendations. HL60 cells were pooled and used to seed 24-
well plates for each assay. Each well received 1 × 106 cells in
RPMI 1,640 medium (Gibco, Thermo Fisher, Madrid, Spain) 48
h prior to inoculation with A. phagocytophilum. Infected cultures
for inoculum were harvested when infection reached 80% and
host cells were mechanically disrupted with a syringe and 26-
gauge needle. Rabbit or sheep purified IgGs (2.2–2.4mg/ml) were
mixed with inoculum (1:1) for 60 min before being placed on
the cell monolayers. Each monolayer then received 100µl of
the inoculum plus IgG mix and plates were incubated at 37◦C
for 30min. The inoculum was removed from the wells and cell
monolayers washed three times with PBS. Complete medium (1
ml) was added to each well and the plates were incubated at
37◦C. The control for each trial included inoculum incubated
with rabbit pre-immune IgG or control sheep IgG. Four replicates
were done for each treatment. After 7 days, cells from all
wells were harvested, resuspended in 1ml PBS and frozen at
−70◦C. Samples were thawed and solubilized with 1% Triton-
X100 and processed for A. phagocytophilum detection by PCR
after DNA extraction using TriReagent (Sigma) according to the
manufacturer’s recommendations. Anaplasma phagocytophilum
infection levels were determined by msp4 real-time PCR
normalizing against human β-actin as described previously
(de la Fuente et al., 2005) but using oligonucleotide primers
MSP4-L (5′-CCTTGGCTGCAGCACCACCTG-3′) and MSP4-
R (5′-TGCTGTGGGTCGTGACGCG3′), with PCR conditions
of 5min at 95◦C and 35 cycles of 10 s at 95◦C, 30 s at 55◦C
and 30 s at 60◦C. Results were compared between treatments
by the Student’s t-test with unequal variance (P = 0.05;
N = 4).
Protein Inhibition Assay
HL60 cells were incubated with 4µM MSP4 and HSP70
recombinant proteins or their combination in culture media
for 1 h at 37◦C and 5% CO2 in a humidified atmosphere.
For antigen combination, equal molar ratios of each protein,
equivalent to one part of HSP70 and two parts of MSP4,
were incubated at 4◦C on a rotator overnight. HL-60 cells
(4 × 105 cells/well) were fixed in 4% paraphormaldehyde
(PFA) in PBS for 1 h at room temperature (RT), and then
incubated with a 6x-His epitope tag monoclonal antibody
(3µg/ml mouse IgG1, Thermo Fisher 4A12E4) for 1 h at
RT. After washing, cells were incubated with FITC-conjugated
goat anti-mouse IgG (1/100, Sigma F2012) for 1 h at RT.
Protein binding was assessed by flow cytometry using a
FACScalibur R© Flow Cytometer, equipped with the CellQuest
Pro R© software (BD-Biosciences, San Jose, CA, USA) as
previously described (Seidman et al., 2015; Hebert et al., 2017).
Incubation with PBS was used as negative control. The viable
cell population was gated according to forward scatter and
side scatter parameters. To determine the effect of MSP4 and
HSP70 recombinant proteins on A. phagocytophilum infection,
HL60 cells were incubated with 4µM MSP4 and HSP70
recombinant proteins or their combination for 1 h, after which
A. phagocytophilum human NY18 isolate bacteria purified as
described above were added and incubated with the host cells in
the continued presence of recombinant protein for 2 h. Unbound
bacteria and proteins were removed and the infection was
allowed to proceed for 48 h. Then, cells were harvested and
infection levels determined by PCR and statistically analyzed
as described above. The Rhipicephalus microplus Subolesin
recombinant protein (SUB; Merino et al., 2011) and PBS
were included as controls. Four replicates were done for each
treatment.
Lamb Immunization and Infection with
A. phagocytophilum
The recombinant MSP4 was formulated alone or combined with
HSP70. Antigen combination was done as described above in
Section Protein Inhibition Assay. Recombinant antigens or saline
control were adjuvated in Montanide ISA 50 V2 (Seppic, Paris,
France; Merino et al., 2013). Nine 3-month old lambs of the
Latxa breed (Basque Country, Spain) were selected from the
experimental sheep flock maintained at NEIKER and were kept
indoor during the experiment. This flock has no known history
of ticks or tick-borne diseases. However, blood of lambs and
their dams were analyzed prior to the start of the study to check
their status for hemoparasites Theileria, Babesia, and Anaplasma
spp. as previously described (Hurtado et al., 2015). All animals
were negative for these hemoparasites. Three groups of 3 lambs
each with similar live weight were formed. Lambs from each
group were injected subcutaneously in the loose skin of the
axilla (armpit) using a sterile syringe with removable needle 20
G × 1′′ (9.0 × 25mm), and taking aseptic precautions. Lambs
were immunized three times on days 55, 30, and 10 before
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experimental infection with 1ml doses of MSP4 (100µg/dose),
MSP4-HSP70 (100µg of equal molar ratios of each protein/dose)
or adjuvant/saline as control. The strain of A. phagocytophilum
used for experimental infection originated from an infected lamb
in Norway, which suffered TBF but was negative to other tick-
borne pathogens (Alberdi et al., 2015; Stuen et al., 2015). The
inoculum consisted of A. phagocytophilum infected heparinised
blood that had been stored at−70◦Cwith 10% dimethyl sulfoxide
(DMSO). Once unfrozen, 1ml of infected blood containing 1.8
× 106 infected neutrophils per ml was intravenously inoculated
into each experimental lamb through the jugular vein using
sterile winged infusion sets with needle 21 G × 3/4′′ (0.8 ×
19mm).
Sheep Samples and Analysis
Whole blood and serum samples were collected from the jugular
vein of each lamb previous to each immunization, daily starting
on infection day during 10 days, and at weekly intervals until
the end of the experiment at 94 dpi (Supplementary Table 1).
Rectal temperatures were taken daily until 10 dpi and then weekly
until 94 dpi (Supplementary Table 1). Lambs were also weighed
periodically (Supplementary Table 1). Hematological analyses
including leukocyte and erythrocyte cell counts, leukocyte cell
differentiation (percent neutrophils, lymphocytes, monocytes
and eosinophils), hemoglobin levels, hematocrit, mean cell
volume (MCV), and mean corpuscular hemoglobin (MCH)
were performed with an electronic counter (Hemavet 950,
Drew, USA) in blood samples collected in EDTA-containing
tubes (Supplementary Table 1). Blood smears stained with
Giemsa stain were examined to investigate the presence of A.
phagocytophilum in blood cells (Supplementary Table 1). At
least 100 neutrophils were counted and examined to calculate
the number of infected neutrophils per milliliter blood of each
lamb throughout the experiment. The differential percent of
A. phagocytophilum-infected neutrophils was calculated as the
difference between values at different dpi and values at 3 dpi
when infected neutrophils were first detected (Supplementary
Table 1).
Analysis of the Antibody Response in
Lambs
An indirect ELISA test was performed to detect IgG antibodies
against MSP4 and HSP70 proteins in immunized and control
lambs using serum samples collected before each immunization
and at 0, 7, 10, and 94 dpi. High absorption capacity polystyrene
microtiter plates were coated with 100µl (0.01µg/µl solution
of purified recombinant MSP4 or HSP70 protein) per well
in carbonate-bicarbonate buffer (Sigma). After an overnight
incubation at 4◦C, coated plates were blocked with 100µl/well of
blocking solution (5% skim milk in PBS). Serum samples or PBS
as negative control were diluted (1:100, v/v) in blocking solution
and 100µl/well were added into duplicate wells of the antigen-
coated plates. After an overnight incubation at 4◦C, the plates
were washed three times with a washing solution (PBS containing
0.05% Tween 20). A donkey anti-sheep IgG-peroxidase conjugate
(Sigma) was added (diluted 1:1000 in blocking solution) and
incubated at room temperature for 1 h. After three washes
with washing solution, 100µl/well of substrate solution (Fast
OPD; Sigma) was added. Finally, the reaction was stopped with
50µl/well of 3N H2SO4 and the optical density (OD) was
measured in a spectrophotometer at 450 nm. Antibody titers were
expressed as OD450nm (ODlambsera ODPBScontrol). The antigen-
specific antibody response in immunized lambs was corroborated
by ELISA using pooled sera collected at 0 dpi, but incubating sera
with A. phagocytophilum purified from infected HL60 human
cells as described above in Section Antibody Inhibition Assay.
Results from rectal temperature and hematological analyses,
differential percent of A. phagocytophilum-infected neutrophils
and antibody titers were compared between immunized and
control groups by two-way ANOVA test (P = 0.05; N = 3).
Analysis of A. phagocytophilum DNA
Levels in Lambs
For the analysis of A. phagocytophilum infection in lambs
during the trial, DNA was extracted from 200µl of blood
using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany),
including negative extraction controls every 9 samples. DNA
was stored at −20◦C until subsequent analysis. The presence
of Anaplasma spp. was firstly determined using a real-time
PCR assay for the screening of piroplasms and Anaplasma
spp. (RTi-PCR1) that targets the 16S rRNA gene of Anaplasma
spp. and the 18S rRNA gene of piroplasms of the genera
Theileria and Babesia (Hurtado et al., 2015). The assay also
includes an internal amplification control (IAC) to monitor for
possible inhibition of the PCR reaction. All samples positive
to Anaplasma spp. in the RTi-PCR1 were analyzed with a
multiplex PCR assay that specifically amplifies the major surface
protein 2 (msp2) gene of A. phagocytophilum, and the msp4
gene of Anaplasma ovis (RTi-PCR2). Sequences of primers and
probes, as well as details on cycling conditions were as reported
previously (Hurtado et al., 2015). Analyses were performed
in 20µl volume reactions using an ABI PRISM 7500 Fast
Sequence Detection System (Applied Biosystems, Foster City,
CA, USA). For the quantitative analysis of A. phagocytophilum
infection levels, DNA was extracted from 200µl blood samples
using Nucleospin 96 Blood (Machery-Nagel, Düren Germany).
A quatitative real-time PCR was conducted on DNA samples
using a Quantitect SYBR Green RT-PCR Kit and a Rotor Gene
Q thermocycler (Qiagen, Inc. Valencia, CA, USA) following
manufacturer’s recommendations. A dissociation curve was run
at the end of the reaction to ensure that only one amplicon
was formed and that the amplicon denatured consistently in
the same temperature range for every sample (Ririe et al.,
1997). The DNA levels were normalized against sheep aldolase B
using primers Ovi-ALDOB-F: CCCATCTTGCTATCCAGGAA
and Ovi-ALDOB-R: TACAGCAGCCAGGACCTTCT, and the
genNorm method (ddCT method as implemented by Bio-Rad
iQ5 Standard Edition, Version 2.0; Livak and Schmittgen, 2001).
Normalized Ct values were compared between immunized and
control groups by Student’s t-test with unequal variance (P =
0.05; N = 3).
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RESULTS
The A. phagocytophilum MSP4 and HSP70
Proteins are Localized on the Bacterial
Membrane and Involved in Pathogen
Infection of HL60 Human Cells
The subcellular localization of MSP4 and HSP70 proteins was
characterized in A. phagocytophilum purified from infected
HL60 human promyelocytic leukemia cells, mock treated or
surface digested with trypsin and loaded onto polyacrylamide
gels for Western blot analysis using rabbit antibodies specific
against recombinant proteins. The results showed that as a
transmembrane protein, MSP4 was partially resistant to trypsin
digestion in A. phagocytophilum from HL60 cells, while HSP70
was extracellular and exposed to protease digestion (Figure 1A).
The apo and bound A. phagocytophilum HSP70 models
showed that the major structural difference between the
two HSP70 tertiary structures is at the C-terminus (residues
400–533), with a 40–90 Å α-carbon backbone root mean
square deviation (RMSD; Supplementary Figure 1A). The A.
phagocytophilum MSP4 showed a 25◦ ± 1◦ tilt from the
membrane with its N/C-terminus oriented toward the cytosol,
and the β-sheets buried within the membrane with remaining
β-hairpin loops exposed extracellularly (Supplementary Figure
1B). The models suggested a limited number of possible MSP4-
HSP70 binding positions due to the membrane orientation of
MSP4 (Supplementary Figure 1C). The energy score of the
optimum MSP4-HSP70 bound state (Supplementary Figure 1C)
was calculated at −46 kcal/mol. Furthermore, although the
residue map showed that the majority of protein-protein contacts
are formed between the β-sheets of MSP4 buried within the
membrane and the C-terminus of HSP70, several contacts
between the β-hairpin loops of MSP4 and the N-terminus of
HSP70 are exposed extracellularly, and therefore these residues
may act as markers for mutational studies and antibody
targeting (Supplementary Figure 1C). These models supported
the interaction between A. phagocytophilum MSP4 and HSP70
proteins when localized on the bacterial membrane.
The binding of HSP70 and MSP4 to HL60 human cells
was characterized using recombinant proteins and E. coli
producing surface-exposed A. phagocytophilum proteins. The
results demonstrated that MSP4 and HSP70 are involved in
binding to human promyelocytic leukemia cells (Figures 1B,C).
Furthermore, E. coli producing themutant HSP70 with truncated
peptide-binding domains that are involved in protein-protein
interactions did not bind to human HL60 cells, thus supporting
the role of this protein in interactions with host cells. The
interaction of recombinant E. coli producing A. phagocytophilum
MSP4 (Figure 1D) and HSP70 (Figure 1E) proteins with HL60
human cells was also characterized by electron microscopy in
comparison with control E. coli cells to provide additional
evidence for the role of these proteins in the interaction with
vertebrate host cells.
To provide additional support for the role of A.
phagocytophilum MSP4 and HSP70 proteins in the interaction
with and infection of vertebrate host cells, recombinant proteins
and antibodies against these proteins were used to evaluate their
effect on pathogen infection of HL60 human cells. Anti-MSP4
and anti-HSP70 or recombinant MSP4 and HSP70 proteins
were incubated with HL60 cells prior to infection with A.
phagocytophilum. The results showed an inhibitory effect of
anti-MSP4 and anti-HSP70 antibodies on infection of human
cells with A. phagocytophilum human NY18 (Figure 2A) and
sheep (Figure 2B) isolates when compared to cells treated with
pre-immune serum. Furthermore, incubation with HSP70 and
MSP4-HSP70 but not MSP4 recombinant proteins inhibited
infection of human cells with A. phagocytophilum human NY18
isolate when compared to cells incubated with PBS or SUB
controls (Figure 2C).
These results evidenced a role for MSP4 and HSP70 proteins
in A. phagocytophilum adhesion to vertebrate host cells, and
suggested a role for HSP70 during pathogen infection. These
results also suggested that these proteins might constitute
candidate protective antigens to prevent or control pathogen
infection.
Experimental Infection with
A. phagocytophilum Correlates with TBF in
Lambs
To gain additional information on the role ofA. phagocytophilum
MSP4 and HSP70 proteins in host-pathogen interactions,
sheep that are natural hosts for this pathogen were selected
for immunization with recombinant proteins followed by
experimental infection with A. phagocytophilum. Groups of
three lambs each were immunized with recombinant MSP4,
MSP4-HSP70 combination or adjuvant/saline control and
infected with a sheep isolate of A. phagocytophilum. Then,
several parameters including rectal temperature, animal weight,
hemoglobin content, and hematological variables were evaluated
in immunized and control A. phagocytophilum-infected lambs
to correlate with TBF main clinical signs (Supplementary
Table 1).
The results showed signs of TBF in lambs infected with A.
phagocytophilum. Evidence of A. phagocytophilum in neutrophils
was obtained for all animals (Supplementary Table 1). Fever was
evident in animals from all groups, primarily between 3 and 9 dpi
(Figure 3A and Supplementary Table 1). Although immunized
lambs tend to gain more weight, differences with controls
were not significant (Supplementary Table 1). Control sheep
showed evidence of anemia at 4 dpi, and between 8 and 10 dpi
with all animals being anemic at 9 dpi, a result that correlated
with low erythrocyte counts at 8–10 dpi (Figure 3B and
Supplementary Table 1). The percent neutrophils in the leukocyte
population increased in all animals after A. phagocytophilum
infection between 4 and 9 dpi (Figure 3C and Supplementary
Table 1). A severe neutropenia was evident in all animals after
59 dpi and lasted until the end of the experiment at 94 dpi
(Figure 3C and Supplementary Table 1). Although monocyte
levels were within normal values throughout the experiment,
an increase was observed in all animals after infection between
2–10, 38–45, and 59–94 dpi (Figure 3D and Supplementary
Table 1).
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FIGURE 1 | Role of A. phagocytophilum MSP4 and HSP70 proteins in interactions with HL60 human cells. (A) A. phagocytophilum (NY18) purified from infected
HL60 human cells were mock treated (−) or surface digested with trypsin (+) and 10µg protein loaded onto polyacrylamide gels for Western blot analysis using rabbit
antibodies produced against recombinant proteins. These experiments have been repeated three times with similar results. (B) E. coli strains were grown and induced
for the production of recombinant proteins. E. coli cells transformed with expression vector alone were used as negative control (Control). Bacteria adhesion to human
HL60 cells was quantitated as the number of colony forming units (CFU) recovered from each test and compared to the control values by Chi2 test. Asterisks denote
statistical significant differences between CFU recovered from E. coli transformed with MSP4 or HSP70 and the control (P < 0.001; N = 2 replicates per treatment).
(C) HL-60 cells were incubated with A. phagocytophilum human NY18 isolate in the presence of recombinant MSP4, HSP70 and their combination. HL60 cells
incubated with PBS served as negative controls. After washing to remove unbound bacteria and proteins, host cells were incubated for 48 h and binding of
recombinant proteins to human host cells was analyzed by flow cytometry. The viable cell population was gated according to forward scatter and side scatter
parameters. (D,E) Representative images of the adhesion of recombinant E. coli producing membrane exposed A. phagocytophilum proteins to human HL60 cells.
(D) E. coli producing MSP4 or (E) HSP70 were incubated with HL60 cells and revealed by TEM to show adhesion to human cells (arrows). Cells incubated with
control bacteria did not show adhesion to HL60 cells. Details of both interacting cells are shown in insets. Scale bars: 5µm (D,E) and 200 nm (insets).
The Antibody Response in Immunized
Lambs Is Specific for A. phagocytophilum
MSP4 and HSP70 Recombinant Proteins
The results showed that anti-MSP4 (Figure 4A) and anti-
HSP70 (Figure 4B) IgG antibody titers were higher in MSP4-
immunized than in control animals from second immunization
until 94 dpi. In MSP4-HSP70 immunized lambs, anti-MSP4 IgG
antibody titers were significantly higher until 10 dpi (Figure 4A),
while anti-HSP70 IgG antibody titers remained higher then
in control animals until 94 dpi (Figure 4B). The increase in
the IgG antibody response to A. phagocytophilum MSP4 and
HSP70 proteins after experimental infection was higher in
immunized than in control animals (Figures 4A,B), suggesting
an anamnestic response that may be protective against pathogen
infection.
The IgG antibody response in MSP4 and MSP4-HSP70
immunized lambs was specific for MSP4 and HSP70 proteins
as supported by the dilution effect observed after incubating
sera collected before infection (0 dpi) with A. phagocytophilum
purified from infected HL60 human cells (Figure 4C). However,
the antibody response in MSP4-immunized lambs raised a
question regarding the anti-HSP70 response in these animals.
Possible explanations to this question are the production of
polyreactive antibodies, and the existence of common B-cell
epitopes between A. phagocytophilum MSP4 and HSP70
proteins. The MSP4 and HSP70 proteins were aligned
and the linear B-cell epitopes were predicted and aligned
to both protein sequences (Supplementary Figure 2A). A
total of 14 and 32 linear B-cell epitopes were predicted for
MSP4 and HSP70, respectively. Only epitopes longer than
8 amino acids were included in further analysis, resulting
in 5 and 12 linear B-cell epitopes identified in MSP4 and
HSP70, respectively. Only one epitope of MSP4 (DGATGYAI)
aligned without gaps to a region of HSP70 (DGQTAVTI)
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FIGURE 2 | Role of A. phagocytophilum MSP4 and HSP70 proteins in infection of HL60 human cells. (A,B) Rabbit antibodies against A. phagocytophilum MSP4 and
HSP70 recombinant proteins or (C) MSP4, HSP70 and MSP4-HSP70 recombinant proteins were used to characterize the inhibition of pathogen infection of HL60
human cells. Rabbit purified IgGs or recombinant proteins were mixed with A. phagocytophilum inoculum of human NY18 or sheep isolates for 60 min before being
placed on the cell monolayers. Treatments included rabbit pre-immune serum, PBS and SUB as negative controls. A. phagocytophilum infection levels were
determined by msp4 real-time PCR normalizing against human β-actin. Results were compared between groups treated with pre-immune and anti-MSP4/HSP70
antibodies (A,B) or between groups treated with PBS or SUB and recombinant proteins (C) by the Student’s t-test with unequal variance (*P < 0.05; N = 4 replicates
per treatment).
with 50% identity (Supplementary Figure 2A). Three epitopes
from HSP70 (FNDAQRQATKDAGTI, AGIKDNSKV and
SNCSTDTLQQ) aligned without gaps to regions of MSP4
(FVAVGRDATLTPDNF, AGIPASNRV and AVCACSLLIS), with
26, 44, and 20% identity, respectively. These results suggested
that antibodies against MSP4 epitopes (i.e., DGATGYAI)
could cross-react with a region of HSP70 (DGQTAVTI), thus
explaining the anti-HSP70 response in MSP4-immunized
lambs. Furthermore, these epitopes were highly conserved
because A. phagocytophilum MSP4 and HSP70 protein
sequences show a high homology between different strains
(Supplementary Figures 2B–D). In 56 of the MSP4 sequences
available containing this region, the B-cell epitope was conserved
(Supplementary Figure 2D). This region was conserved in
all HSP70 sequences available in GenBank (Supplementary
Figure 2D).
Immunization of Lambs with
A. phagocytophilum MSP4 and
MSP4-HSP70 Recombinant Proteins Is
Only Partially Protective against TBF
To address the role of A. phagocytophilum MSP4 and HSP70
proteins as potential targets for the development of vaccines
for the control of pathogen infection in vertebrate hosts, their
potential protective capacity was characterized in immunized
lambs.
The IgG antibody levels to MSP4 and HSP70 antigens
remained higher after infection in immunized animals
when compared to controls (Figures 4A,B). Although
all animals showed signs of fever after infection with
similar fever relapses, rectal temperature decreased faster
in lambs immunized with MSP4-HSP70 (Figure 3A). The
anemia typical of TBF was evident in control sheep at
8–10 dpi, while in immunized animals it did not occur
(MSP4 group) or was observed at 9 dpi only (MSP4-
HSP70 group; Figure 3B). Erythrocyte counts were not
affected in immunized animals (Supplementary Table 1).
The analysis of leukocytes, lymphocytes and eosinophils
showed lower values at various dpi in immunized animals
when compared to controls (Supplementary Table 1). In
contrast, neutrophil and monocyte levels were higher in
immunized animals when compared to controls at different
dpi (Figures 3C,D; Supplementary Table 1). These results
showed that while immunized animals presented evidence
of TBF such as fever and neutropenia, the response to
immunization resulted in less severe anemia in response to
infection.
Although the percent of infected neutrophils was apparently
higher in immunized than in control animals at some
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FIGURE 3 | Evidence of TBF in lambs experimentally infected with A. phagocytophilum sheep isolate. Groups of three lambs each were immunized with recombinant
MSP4, MSP4-HSP70 combination or adjuvant/saline control and experimentally infected with a sheep isolate of A. phagocytophilum. (A) Rectal temperatures were
taken daily until 10 dpi and then weekly until 94 dpi. (B–D) Whole blood was collected in EDTA-containing tubes from the jugular vein of each lamb at different time
points for different hematological analyses including (B) hemoglobin, and percent (C) neutrophils and (D) monocytes for leukocyte cell differentiation using an
electronic counter (Hemavet 950, Drew, USA). Results from rectal temperature and hematological analyses were compared between immunized and control groups
by two-way ANOVA test (*P < 0.05; N = 3 replicates per treatment). Red and blue asterisks denote statistical significant differences between MSP4-HSP70 and
MSP4 immunized animals and controls, respectively.
dpi, the results suggested differences in the initial infection
rate despite the injection of the same amount of unfrozen
infected blood (Supplementary Table 1). These differences
could be explained by variations in cell viability between
different inoculums, resulting in animal-to-animal variations
in the initial infection rate. Therefore, the differential percent
of infected neutrophils with respect to the initial value at
3 dpi was used to characterize the effect of vaccination
to normalize for these differences. The results showed a
significant decrease in A. phagocytophilum-infected neutrophils
in animals immunized with the MSP4-HSP70, but not MSP4
antigen at 8–10 dpi when compared to controls (Figure 5A).
Furthermore, the A. phagocytophilum normalized DNA levels
were significantly lower in lambs immunized with MSP4
and MSP4-HSP70 antigens at 17 dpi (Figure 5B). Taken
together, these results suggested that the number of infected
neutrophils decreased at 8–10 dpi in response to immunization
with MSP4-HSP70, while pathogen levels per cell were
lower in immunized lambs when compared to controls at
17 dpi.
The Antibodies against Recombinant
Proteins in Immunized Lambs Do Not
Inhibit the A. phagocytophilum Infection of
HL60 Human Cells
An antibody inhibition assay using IgG from immunized sheep at
0 and 94 dpi was conducted to further characterize the antibody
response in immunized lambs in relation with the protective
capacity of MSP4 and MSP4-HSP70 antigens (Figure 6).
While rabbit IgG antibodies against A. phagocytophilum
MSP4 and HSP70 recombinant proteins inhibited pathogen
infection of HL60 human cells (Figures 2A, 7), sheep IgG
collected from immunized animals before infection (0
dpi) and after infection at the end of the experiment (94
dpi) did not affect pathogen infection (Figure 6). These
results evidenced differences in the IgG response between
immunized rabbits and lambs, and provided support
for the limited protection against A. phagocytophilum
infection observed in sheep immunized with MSP4 and
MSP4-HSP70.
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FIGURE 4 | Antibody response in lambs immunized with A. phagocytophilum MSP4 and MSP4-HSP70 proteins. Groups of three lambs each were immunized with
recombinant MSP4, MSP4-HSP70 combination or adjuvant/saline control and experimentally infected with a sheep isolate of A. phagocytophilum. An indirect ELISA
test was performed to detect IgG antibodies against (A) MSP4 and (B) HSP70 proteins in immunized and control lambs using serum samples collected before each
immunization and at 0, 7, 10, and 94 dpi. Antibody titers were expressed as OD450nm (ODlambsera−ODPBScontrol ). The results were compared between immunized
and control groups by two-way ANOVA test (*P < 0.05; N = 3 replicates per treatment). (C) The antigen-specific IgG antibody response in immunized lambs was
corroborated by ELISA using pooled sera collected at 0 dpi, but incubating sera with different concentrations of A. phagocytophilum purified from infected HL60
human cells.
DISCUSSION
Anaplasma phagocytophilum transmembrane and surface
proteins are involved in infection of vertebrate host
cells (Seidman et al., 2015; Truchan et al., 2016). The A.
phagocytophilum MSP4 and HSP70 proteins were previously
shown to interact when localized on the bacterial membrane,
with a possible role during pathogen infection of tick cells
(Villar et al., 2015b). These results, together with the finding that
A. phagocytophilum evolved common molecular mechanisms
to establish infection in tick vectors and vertebrate hosts (de
la Fuente et al., 2016a), suggested the hypothesis that MSP4
and HSP70 proteins have similar functions in host-pathogen
and tick-pathogen interactions with possible implications as
potential targets for the development of vaccines for the control
of pathogen infection in both ticks and vertebrate hosts.
To address this hypothesis, we first characterized the role
of these bacterial proteins in the infection of vertebrate host
cells. The results using A. phagocytophilum derived from infected
HL60 human cells corroborated those previously obtained with
A. phagocytophilum derived from ISE6 tick cells (Villar et al.,
2015b). The results showed that MSP4 is a transmembrane
protein in Anaplasma spp. (de la Fuente et al., 2001), while
HSP70 was probably translocated to the cell surface by still
unknown mechanisms in which the bacterial type IV secretion
system (T4SS) may be involved (Niu et al., 2006; Lin et al.,
2007; Villar et al., 2015b). The binding of HSP70 and MSP4
to HL60 human cells was characterized using two alternative
models based on recombinant proteins and E. coli producing
surface-exposedA. phagocytophilum proteins with similar results,
therefore supporting their role in the interaction with host cells.
Although it is possible that the production of A. phagocytophilum
proteins in E. coli may alter bacterial surface to cause binding to
HL60 human cells not mediated by MSP4 and HSP70 proteins,
previous results using this system with A. marginale MSP1a and
MSP1b (de la Fuente et al., 2001) and with A. phagocytophilum
proteins in tick cells (Villar et al., 2015b) makes this possibility
unlikely. Furthermore, E. coli producing the mutant HSP70 with
truncated peptide-binding domains that are involved in protein-
protein interactions (Villar et al., 2015b) did not bind to human
HL60 cells, therefore supporting the role of this protein in
interactions with host cells.
Protein models supported the interaction between A.
phagocytophilum MSP4 and HSP70 proteins when localized on
the bacterial membrane, which was previously demonstrated
in tick cells and may be functionally relevant for pathogen
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FIGURE 5 | Anaplasma phagocytophilum infection levels in immunized and control lambs. (A) Blood smears stained with Giemsa stain were examined to investigate
the presence of A. phagocytophilum in blood cells. At least 100 neutrophils were counted and examined to calculate the number of infected neutrophils per milliliter
blood of each lamb. The differential percent of A. phagocytophilum-infected neutrophils was calculated as the difference between values at different dpi and values at
3 dpi when infected neutrophils were first detected. The results were compared between immunized and control groups by two-way ANOVA test (*P < 0.05; N = 3
replicates per treatment). (B) For the quantitative analysis of A. phagocytophilum infection levels, a quatitative real-time PCR was conducted. The A. phagocytophilum
DNA levels were normalized against sheep aldolase B using the genNorm method (ddCT method as implemented by Bio-Rad iQ5 Standard Edition, Version 2.0).
Normalized Ct values were compared between immunized and control groups by Student’s t-test with unequal variance (*P < 0.05; N = 3 replicates per treatment).
FIGURE 6 | Role of antibodies against recombinant proteins from immunized lambs in the inhibition of A. phagocytophilum infection of HL60 human cells. Sheep IgG
antibodies against A. phagocytophilum MSP4 and MSP4-HSP70 recombinant proteins were obtained from control and immunized sheep at 0 and 94 dpi and used to
characterize the inhibition of pathogen infection of HL60 human cells. Treatments included purified IgGs from rabbit pre-immune, anti-MSP4 and anti-HSP70 sera.
Purified IgGs were mixed with A. phagocytophilum inoculum of human NY18 isolate for 60 min before being placed on the cell monolayers. A. phagocytophilum
infection levels were determined by msp4 real-time PCR normalizing against human β-actin. Results were compared between groups treated with pre-immune/control
and anti-MSP4/HSP70 antibodies by the Student’s t-test with unequal variance (*P < 0.05; N = 4 replicates per treatment).
infection of both tick and vertebrate host cells (Villar et al.,
2015b). Antibody inhibition assays showed that as previously
discussed in the experiments using ISE6 tick cells (Villar
et al., 2015b), antibodies against MSP4 and HSP70 proteins
could affect the interaction between bacterial ligands and tick
receptors to interfere with infection or affect the interaction with
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11 July 2017 | Volume 7 | Article 307
Contreras et al. Anaplasma-Host Interactions
FIGURE 7 | Anaplasma phagocytophilum HSP70 and MSP4 are necessary for pathogen infection of host cells. Based on the results of this study, a model was
developed to explain the role of HSP70 and MSP4 during pathogen infection of host cells. HSP70 and MSP4 form a complex on the bacterial membrane where
MSP4 probably acts a doking protein for HSP70. The incubation of HL60 human cells with recombinant HSP70 or MSP4-HSP70 interacting proteins inhibits infection
by interfering with pathogen interaction with host cells mediated by HSP70, which is necessary for infection. However, the addition of recombinant MSP4 does not
affect infection because the interaction of bacterial HSP70 with host cells occurs and is sufficient for infection. The anti-MSP4 antibodies probably inhibit infection
through binding to MSP4 at the MSP4-HSP70 interaction site, thus preventing HSP70 adhesion to host cells. The anti-HSP70 antibodies bind to HSP70 and prevent
the interaction with host cells required for pathogen infection.
proteins functionally important for bacterial infection and/or
multiplication in host cells. However, the inhibition assay using
recombinant proteins suggested different roles for HSP70 and
MSP4 during pathogen infection of host cells (Figure 7). While
HSP70 seems to be directly involved in the pathogen interaction
with host cells, MSP4 may acts as a doking protein for HSP70
to form the MSP4-HSP70 complex on the bacterial membrane
(Figure 7). These results extended previous findings in tick cells
(Villar et al., 2015b), supporting the role of MSP4 and HSP70
proteins in A. phagocytophilum infection and/or adhesion to
vertebrate host cells.
The role of Anaplasma MSPs and other outer membrane
proteins and invasins in adhesion to tick and vertebrate host cells
for bacterial infection has been demonstrated in A. marginale
and A. phagocytophilum (de la Fuente et al., 2001; Garcia-Garcia
et al., 2004; Ge and Rikihisa, 2007; Rikihisa, 2011; Ojogun et al.,
2012; Severo et al., 2012, 2013; Kahlon et al., 2013; Seidman et al.,
2015; Truchan et al., 2016; Hebert et al., 2017). This mechanism
appears to be conserved in other tick-borne pathogens, and in
pathogen interactions with other arthropod vector species (de la
Fuente et al., 2017). HSP70 was shown to relocate to the Bacillus
subtilis membrane to restore membrane structure and function
after ethanol stress (Seydlová et al., 2012), and to function in
the molecular processing of Borrelia burgdorferi flagellin (Scopio
et al., 1994). This protein may be functionally relevant at the
A. phagocytophilum-host interface, and may interact with other
membrane proteins for its function during pathogen infection
(Susin et al., 2006; Multhoff, 2007).
To evaluate the potential protective capacity of these
proteins, lambs that are natural hosts for this pathogen were
immunized with recombinant MSP4, MSP4-HSP70 combination
or adjuvant/saline control and infected with a sheep isolate of A.
phagocytophilum. The MSP4-HSP70 combination was included
based on evidence of protein-protein interactions, suggesting a
physical and/or functional connection between these proteins
(Villar et al., 2015b).
The results evidenced signs of TBF such as fever, anemia,
and neutropenia in lambs infected with A. phagocytophilum,
therefore validating the model for the comparative analysis
between immunized and control animals. In sheep and dogs,
A. phagocytophilum infection is accompanied by fever of
approximate 7 days duration, which is the main clinical sign of
TBF (Eberts et al., 2011; Stuen et al., 2011; Severo et al., 2013). The
severe leukopenia and especially the prolonged neutropenia that
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accompanies the disease are also evident with TBF (Eberts et al.,
2011; Stuen et al., 2011; Severo et al., 2013). Immune suppression
by impaired antibody and lymphocyte response and reduced
oxidative burst, together with anemia andmonocytosis have been
also reported in animals infected withA. phagocytophilum (Whist
et al., 2003; Eberts et al., 2011). Weaning weight is also affected in
lambs infected with A. phagocytophilum (Grøva et al., 2011).
The immunized lambs raised an antibody response that was
specific for A. phagocytophilum MSP4 and HSP70 recombinant
proteins. However, MSP4-immunized lambs developed an anti-
HSP70 response. One possible explanation to this finding was
the production of polyreactive antibodies, which constitute a
major component of the natural antibodies that bind with low
affinity to structurally unrelated antigens with broad antibacterial
activity (Gunti and Notkins, 2015). Additionally, the analysis
of protein sequences showed the existence of common B-
cell epitopes between A. phagocytophilum human isolate MSP4
and HSP70 proteins that may also contribute to serum cross-
reactivity. The B-cell epitopes are protein regions that bind to
antibodies. Most epitopes are composed of different parts of the
polypeptide chain that are brought into spatial proximity by the
three-dimensional structure of the protein. These discontinuous
epitopes can also react with continuous peptide fragments (i.e.,
linear epitopes) within the protein (Larsen et al., 2006). Epitopes
can be understood as “antigenic determinants” within proteins
and homology between linear epitopes can results in antibody
cross-reactivity (Terajima et al., 2013).
Despite the effect of A. phagocytophilum infection on the
impairment of antibody response in sheep (Whist et al., 2003),
the results showed that IgG antibody levels to MSP4 and HSP70
antigens remained higher after infection in immunized animals
when compared to controls. In contrast to the results reported
in lambs immunized with inactivated A. phagocytophilum (Stuen
et al., 2015), the number of fever relapses was similar between
immunized and control animals, supporting that antigen-specific
response is different from that obtained with whole organisms.
The immunization with MSP4-HSP70 resulted in a decrease
in the percent of infected neutrophils and pathogen levels
per cell, supporting that immunization with MSP4-HSP70 was
only partially protective for the control of A. phagocytophilum
infection of neutrophils.
A previous experiment using a crude A. phagocytophilum
protein extract for immunization did not protect against
pathogen infection in sheep, but immunized lambs had reduced
levels of infection (Stuen et al., 2015). The authors discussed
that the lack of protection was probably due to the presence
of not protective dominant antigens in the vaccine preparation,
stressing the need for the identification of protective antigens
conserved among different strains (Stuen et al., 2015). The
results obtained here were similar to those reported previously
by Stuen et al. (2015), but using two proteins shown to be
highly conserved and involved in pathogen infection and/or
interaction with host cells. The failure to protect lambs from
A. phagocytophilum infection after immunization with MSP4
and MSP-HSP70 antigens may be due to several factors.
Although these proteins seem to be involved in host-pathogen
interactions and infection, other proteins may be also necessary
for infection within this mechanism or as part of alternative
mechanisms of infection. The results showed that IgG antibodies
rose in immunized lambs did not inhibit A. phagocytophilum
infection of HL60 human cells, suggesting differences between
rabbit and sheep IgG responses that may be associated with
epitope recognition in MSP4 and HSP70 proteins. These
differences in the immune response between rabbits and sheep
could be used to identify candidate protective regions or
epitopes in MSP4 and HSP70 proteins to increase vaccine
efficacy. Additionally, the intravenous inoculation of infected
blood is different from natural infection after tick bite, and
may affect the evaluation of the protective response after
immunization.
CONCLUSIONS
The A. phagocytophilum transmembrane and surface proteins
play a crucial role during infection and multiplication in host
neutrophils (Ge and Rikihisa, 2007; Rikihisa, 2011; Severo
et al., 2012, 2013; Seidman et al., 2015; Truchan et al., 2016).
However, the results reported here provided the first evidence
for the role of A. phagocytophilum MSP4 and HSP70 proteins
in this process. These results suggested that while membrane-
localized MSP4 and HSP70 were involved in A. phagocytophilum
interaction with host cells, HSP70 was directly implicated
in pathogen infection. As for other intracellular pathogens,
cellular immunity is essential for an effective protection against
infection by Anaplasma spp. (Palmer et al., 1999; Hajdušek
et al., 2013; de la Fuente et al., 2016a; Shaw et al., 2017).
However, previous experiments have provided evidence that
antibodies to bacterial proteins have a protective effect on
infected hosts (Kaylor et al., 1991; Messick and Rikihisa, 1994;
Sun et al., 1997; de la Fuente et al., 2003; Gomes-Solecki,
2014; Stuen et al., 2015). The results obtained here showed
that the A. phagocytophilum MSP4-HSP70 antigen was only
partially protective against pathogen infection in sheep. This
limited protection may be associated with several factors,
including the recognition of non-protective epitopes by IgG from
immunized lambs. Nevertheless, these antigens may constitute
candidate protective antigens for the development of vaccines
against TBF in combination with other antigens. Focusing on
the characterization of host protective immune mechanisms
and protein-protein interactions at the host-pathogen interface
may lead to the discovery and design of new protective
antigens (de la Fuente et al., 2016c,d). Additionally, proteins
involved in tick-pathogen and host-pathogen interactions such
as A. phagocytophilum MSP4 and HSP70 may be used to
develop double effect vaccines targeting infection in both
vertebrate hosts and tick vectors (de la Fuente and Contreras,
2015).
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